Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
From OmniJournal
Revision as of 07:34, 29 July 2020 by Vinucube(talk | contribs)(Created page with "test")